DYRK1A inhibitors and perspectives for the treatment of alzheimer's disease (2023)
Source: Current Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE ALZHEIMER, INIBIDORES DE ENZIMAS
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: http://dx.doi.org/10.2174/0929867329666220620162018. Acesso em: 30 maio 2023.APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Schuler, M. C. G. M., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Schuler MCGM, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2023 maio 30 ] Available from: http://dx.doi.org/10.2174/0929867329666220620162018Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Schuler MCGM, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2023 maio 30 ] Available from: http://dx.doi.org/10.2174/0929867329666220620162018